2021 Health Care Heroes: Pulmonogist led Eli Lilly’s COVID-19 antibody trial at Franciscan
Lilly’s BLAZE-1 study examined antibody therapy engineered from one of the first individuals in the United States to recover from COVID and was specifically designed to attack the virus that causes it, SARS-CoV-2.